Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$3.8 - $5.91 $198,740 - $309,093
52,300 Added 90.64%
110,000 $442,000
Q2 2022

Aug 15, 2022

BUY
$3.18 - $9.85 $183,486 - $568,345
57,700 New
57,700 $281,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.62B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Oasis Management CO Ltd. Portfolio

Follow Oasis Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oasis Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Oasis Management CO Ltd. with notifications on news.